Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164164 · ClinicalTrials.gov registry record · Phase 3
HalfLytely Bowel Prep System for Colonoscopy
A Phase 3 study of Colonoscopy, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT00164164: Completed Phase 3 study of Colonoscopy, sponsored by Braintree Laboratories.
NCT00164164 is a Phase 3 study of Colonoscopy that has completed, run by Braintree Laboratories. The registered enrollment target is 200 participants, below the 492-participant average among 20 other Colonoscopy trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00164164, a Phase 3 study of Colonoscopy, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the this study was to compare the safety and efficacy of HalfLytely (2L NULYTELY + 20mg bisacodyl) to NULYTELY for preparation prior to colonoscopy.
Conditions Studied
Interventions
- DRUG HalfLytely
- DRUG NuLytely
Study Locations (2)
Massachusetts
- - Braintree
Texas
- - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1999-08 |
| Phase | Phase 3 |
What the finished NCT00164164 record still lists
NCT00164164 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 492-participant average among 20 other Colonoscopy trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 2 interventions - of which HalfLytely is the first listed.
NCT00164164 reports a single indexed study location in Massachusetts, Texas.
Frequently Asked Questions
What is clinical trial NCT00164164 about?
NCT00164164 is a clinical study titled "HalfLytely Bowel Prep System for Colonoscopy". The purpose of the this study was to compare the safety and efficacy of HalfLytely (2L NULYTELY + 20mg bisacodyl) to NULYTELY for preparation prior to colonoscopy.
What is the current status of trial NCT00164164?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 1999-08.
What conditions does trial NCT00164164 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT00164164?
The interventions under investigation include: HalfLytely (DRUG), NuLytely (DRUG).
Who is sponsoring clinical trial NCT00164164?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00164164 being conducted?
This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00164164's enrollment target sits among peer trials
200 12th of 20 higher than 8 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
-
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
COMPLETED · Phase 3
-
BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
COMPLETED · Phase 3
-
A Safety Study of 3 Different Bowel Cleansing Preparations
COMPLETED · Phase 3
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia